Access to anti-retroviral drugs, female in Guinea-Bissau
Guinea-Bissau: Access to anti-retroviral drugs, female was 89.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Guinea-Bissau, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Guinea-Bissau stood at 89.0%. That is the highest value across all 25 years on record.
The figure is up 20.3% on the previous year and up 229.6% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Guinea-Bissau peaked at 89.0% in 2024 and was at its lowest, 0.0%, in 2000.
Guinea-Bissau ranks 35th of 141 countries on this measure, in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Guinea-Bissau, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 1.0% | — |
| 2007 | 2.0% | +100.0% |
| 2008 | 6.0% | +200.0% |
| 2009 | 8.0% | +33.3% |
| 2010 | 10.0% | +25.0% |
| 2011 | 14.0% | +40.0% |
| 2012 | 22.0% | +57.1% |
| 2013 | 23.0% | +4.5% |
| 2014 | 27.0% | +17.4% |
| 2015 | 32.0% | +18.5% |
| 2016 | 40.0% | +25.0% |
| 2017 | 41.0% | +2.5% |
| 2018 | 56.0% | +36.6% |
| 2019 | 57.0% | +1.8% |
| 2020 | 60.0% | +5.3% |
| 2021 | 67.0% | +11.7% |
| 2022 | 74.0% | +10.4% |
| 2023 | 74.0% | +0.0% |
| 2024 | 89.0% | +20.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.7% | 0.0% | 8.0% | 10 |
| 2010s | 32.2% | 10.0% | 57.0% | 10 |
| 2020s | 72.8% | 60.0% | 89.0% | 5 |
Countries ranked near Guinea-Bissau
More gender data for Guinea-Bissau
- Child population (UN estimates and projections) 894.88 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.69 % change on previous year (2030)
- Population 1,594 (2030)
- Working-age population (UN estimates and projections) 1,594 (2030)
- Population (UN estimates and projections), annual growth rate 2.65 % change on previous year (2030)
- Age population, age 00, female, interpolated 30,905 (2025)
- Age population, age 00, male, interpolated 31,871 (2025)
- Age population, age 01, female, interpolated 30,253 (2025)
- Age population, age 01, male, interpolated 31,136 (2025)
- Age population, age 02, female, interpolated 29,772 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Guinea-Bissau?
- Access to anti-retroviral drugs, female in Guinea-Bissau was 89.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Guinea-Bissau?
- The highest recorded value was 89.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Guinea-Bissau?
- The lowest recorded value was 0.0% in 2000.
- How does Guinea-Bissau rank for access to anti-retroviral drugs, female?
- Guinea-Bissau ranks 35th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Guinea-Bissau?
- Over the last ten years it is up 229.6%. The long-run trend across the full record is volatile.
- Where does this Guinea-Bissau data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.